View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
March 23, 2021

UK trials new technology to detect known Covid-19 variants

The UK Government has announced the trial of a technology that can quickly identify new Covid-19 mutations by showing whether positive test specimens contain known variants.

The UK Government has announced the trial of a technology that can quickly identify new Covid-19 mutations by showing whether positive test specimens contain known variants.

Free Report
img

Build resilience in the face of COVID-19 disruption

COVID-19 has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities. Are you interested in actionable insights on the business challenges induced by the pandemic? GlobalData's cross-sector report analyzes the significance of this major disruptive theme across industry verticals. It provides side-by-side research of alternative datasets to present you with unique quantitative analysis of the effects of COVID-19 and how these differ across sectors. Additionally, it offers qualitative analysis of each sector and analyzes COVID-19’s impact on leading companies. Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today.
by GlobalData
Enter your details here to receive your free Report.

Known as ‘genotype assay testing’, the technology is currently being trialled by the government in NHS Test and Trace laboratories.

At present, detecting a case of variants of concern takes around four to five days for genomic sequencing.

The latest technology could potentially halve the time taken to detect whether a positive Covid-19 sample has a variant of concern and could be used along with standard Covid-19 testing to detect cases rapidly.

UK Health and Social Care Secretary Matt Hancock said: “We must not stand still if we are to beat Covid-19 and safely ease restrictions in the coming months.

“That is why our goal is to eventually test every Covid positive sample for mutations, that indicate known variants, using this groundbreaking new technology.

“This type of testing will help us rapidly identify variant cases and trace contacts quicker than ever before, helping stop outbreaks in their tracks and ensuring we can continue to follow the roadmap we have set out to get back to normal life.”

According to the government, controlling variants of concerns is the key to cautiously easing lockdown restrictions in England.

In addition to the extensive testing capacity NHS Test and Trace has in place, surge testing is deployed in various targeted areas to aid in suppressing, controlling and better understanding variants of concern.

UK Health Minister Lord Bethell said: “Using this test to identify known variant of concern cases has the potential to accelerate our knowledge and understanding of variants of concern and halt their spread across the country.”

Related Companies

Free Report
img

Build resilience in the face of COVID-19 disruption

COVID-19 has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities. Are you interested in actionable insights on the business challenges induced by the pandemic? GlobalData's cross-sector report analyzes the significance of this major disruptive theme across industry verticals. It provides side-by-side research of alternative datasets to present you with unique quantitative analysis of the effects of COVID-19 and how these differ across sectors. Additionally, it offers qualitative analysis of each sector and analyzes COVID-19’s impact on leading companies. Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network